ライフサイエンスコーパス: hemochromatosis

1 und to be associated with milder symptoms of hemochromatosis.

2 is central to the pathogenesis of hereditary hemochromatosis.

3 available for the major forms of hereditary hemochromatosis.

4 ad disorders, collectively termed hereditary hemochromatosis.

5 , and review current treatments for neonatal hemochromatosis.

6 oad, such as the thalassemias and hereditary hemochromatosis.

7 lation is central to the pathogenesis of HFE hemochromatosis.

8 ovel suggestions to improve the treatment of hemochromatosis.

9 rtin, are associated with autosomal dominant hemochromatosis.

10 use of the iron-overload disorder hereditary hemochromatosis.

11 form of the iron overload hereditary disease hemochromatosis.

12 pic expression of Wilson disease and genetic hemochromatosis.

13 inherited disorder of iron metabolism type I hemochromatosis.

14 understanding of Wilson disease and genetic hemochromatosis.

15 rine' focus was elaborated in an overview of hemochromatosis.

16 n-depleted HFE hemochromatosis, and juvenile hemochromatosis.

17 orm of the iron overload disease, hereditary hemochromatosis.

18 ropoietin, iron deficiency, thalassemia, and hemochromatosis.

19 e pathogenesis of the iron overload disorder hemochromatosis.

20 or cirrhosis, one of the main morbidities of hemochromatosis.

21 and TfR2 cause autosomal-recessive forms of hemochromatosis.

22 TfR2) and HFE are associated with hereditary hemochromatosis.

23 es the established treatment for HFE-related hemochromatosis.

24 in the HFE gene, responsible for hereditary hemochromatosis.

25 poiesis but is pathologic in thalassemia and hemochromatosis.

26 It is defective in hereditary hemochromatosis.

27 ted with the iron overload disorder known as hemochromatosis.

28 ostasis and associated with human hereditary hemochromatosis.

29 r high-risk genetic screening for hereditary hemochromatosis.

30 utweigh the risks and costs of screening for hemochromatosis.

31 several organs similar to classic hereditary hemochromatosis.

32 (weh(Tp85c-/-)) and in patients with type 4 hemochromatosis.

33 revention of iron accumulation in hereditary hemochromatosis.

34 primary portal for intestinal iron entry in hemochromatosis.

35 cardiac stress exacerbated by iron overload hemochromatosis.

36 ssociated with the iron overloading disorder hemochromatosis.

37 ns reportedly seen in humans with hereditary hemochromatosis.

38 is mutated in the iron-overloading disorder hemochromatosis.

39 lin (HJV) cause severe, early-onset juvenile hemochromatosis.

40 myloidosis, cardiac sarcoidosis, and cardiac hemochromatosis.

41 istently identify a link to overt hereditary hemochromatosis.

42 the iron overload phenotype in patients with hemochromatosis.

43 d not carry genetic variants associated with hemochromatosis.

44 form of the iron-overload disease hereditary hemochromatosis.

45 e liver disease) can cause acquired forms of hemochromatosis.

46 recognized model of the iron-loading disease hemochromatosis.

47 markers in HFE C282Y homozygotes at risk for hemochromatosis.

48 is C, alcoholic liver disease, or hereditary hemochromatosis.

49 he first stage of fibrogenesis in hereditary hemochromatosis.

50 f insulin resistance, and iron burden in HFE hemochromatosis.

51 anemia, sideroblastic anemia, and hereditary hemochromatosis.

52 n accumulation, as observed in patients with hemochromatosis.

53 ngs in advanced iron overload resulting from hemochromatosis.

54 ral history of iron deposition in hereditary hemochromatosis.

55 ac diagnoses were familial amyloidosis (11), hemochromatosis (1), restrictive cardiomyopathy and card

56 regulators or the hepcidin gene itself cause hemochromatosis, a common genetic disorder.

57 Inactivating mutations cause juvenile hemochromatosis, a severe iron overload disorder.

58 se, primary sclerosing cholangitis, neonatal hemochromatosis, acute liver failure (from the Pediatric

59 acute myeloid leukemia, Alzheimer's disease, hemochromatosis, age-related macular degeneration (AMD),

60 Less common causes include hemochromatosis, alpha1-antitrypsin deficiency, autoimmu

61 viruses, and oxyradical disorders including hemochromatosis, also generate reactive oxygen/nitrogen

62 uvelin (Hjv)-knockout mice, another model of hemochromatosis, also had increased expression of GLUTs,

63 common HFE mutations resulting in phenotypic hemochromatosis among C282Y heterozygotes have been iden

64 1) What is the risk for developing clinical hemochromatosis among those with a homozygous C282Y geno

65 Hereditary hemochromatosis, an iron overload disease caused by a de

66 Iron overload is the hallmark of hereditary hemochromatosis and a complication of iron-loading anemi

67 e pathophysiology of Wilson disease, genetic hemochromatosis and alpha-1 antitrypsin deficiency as we

68 tion focuses on the disorders Wilson disease hemochromatosis and alpha-one antitrypsin deficiency, an

69 Iron overload in hereditary hemochromatosis and beta-thalassemia intermedia is cause

70 Second, we evaluated mice combining the hemochromatosis and beta-thalassemia phenotypes.

71 nt of clinical conditions such as hereditary hemochromatosis and beta-thalassemia.

72 t relatively unexplored, association between hemochromatosis and CRC.

73 ned to investigate the presence of the DR in hemochromatosis and describe its associations.

74 myloidosis, cardiac sarcoidosis, and cardiac hemochromatosis and imaging techniques used to facilitat

75 n overload in nearly all forms of hereditary hemochromatosis and in untransfused iron-loading anemias

76 to prevent iron overload in murine models of hemochromatosis and induce iron-restricted erythropoiesi

77 iency results in iron overload in hereditary hemochromatosis and ineffective erythropoiesis.

78 Four selected topics, Wilson disease, hemochromatosis and iron overload disorders, alpha-1 ant

79 data has also advanced our understanding of hemochromatosis and iron overload disorders.

80 The Hemochromatosis and Iron Overload Screening (HEIRS) Stud

81 The Hemochromatosis and Iron Overload Screening (HEIRS) Stud

82 ts and iron dysfunctions, such as hereditary hemochromatosis and iron overload.

83 sm may account for individual variability in hemochromatosis and iron status connected with liver and

84 verload and deficiency, including hereditary hemochromatosis and iron-refractory iron deficiency anem

85 rders of iron metabolism, such as hereditary hemochromatosis and iron-refractory iron-deficiency anem

86 n is inappropriately decreased in hereditary hemochromatosis and is abnormally increased in the anaem

87 Portal inflammation occurs in hemochromatosis and is independently associated with the

88 ontribute to behavioral symptoms in NBIA and hemochromatosis and is relevant to patients with abnorma

89 own to reduce iron overload in patients with hemochromatosis and may be an option for patients who ca

90 cular insight into immune function in type I hemochromatosis and other disorders of iron homeostasis,

91 e selected disorders-Wilson disease, genetic hemochromatosis and other hereditary iron overload disor

92 ights into the pathophysiology of hereditary hemochromatosis and the anaemia of chronic diseases have

93 on, stimulating the development of the DR in hemochromatosis and this correlates strongly with hepati

94 is commonly found in plasma of patients with hemochromatosis and transfusional iron overload, Zip14-m

95 Advancements in diagnosis of hemochromatosis and Wilson disease may lead to earlier d

96 ons on genetics, diagnosis and management of hemochromatosis and Wilson disease over the past 18 mont

97 s have been made in the genetic diagnosis of hemochromatosis and Wilson disease.

98 For genetic hemochromatosis and Wilson's disease, studies focused on

99 ates for the molecular defect underlying Hfe hemochromatosis, and BMP6-like agonists may have a role

100 y iron deficiency anemia, cancer, hereditary hemochromatosis, and ineffective erythropoiesis, such as

101 mia (ferritin < 10 ng/mL), iron-depleted HFE hemochromatosis, and juvenile hemochromatosis.

102 ver failure, liver transplantation, neonatal hemochromatosis, and the Biliary Atresia Research Consor

103 hepatic and intestinal transport proteins in hemochromatosis, and the histopathologic interpretive ch

104 rs such as the hemophilias, Gaucher disease, hemochromatosis, and the porphyrias.

105 increased in inflammation and suppressed in hemochromatosis, and they may have diagnostic importance

106 iron homeostasis; all of the known causes of hemochromatosis appear to prevent this system from funct

107 beta-Thalassemia and HFE-related hemochromatosis are 2 of the most frequently inherited d

108 adipocyte ferroportin expression because of hemochromatosis are associated with decreased adipocyte

109 Patients with hemochromatosis are instructed to avoid taking supplemen

110 Patients with hereditary hemochromatosis are known to have an increased risk for

111 e authors draw attention again to hereditary hemochromatosis as a cause of preventable organ dysfunct

112 Hemochromatosis-associated FPN mutations, therefore, eit

113 with up to 10% to 33% eventually developing hemochromatosis-associated morbidity.

114 y BMP6 can be modulated by each of the three hemochromatosis-associated proteins: HJV (hemojuvelin),

115 ced oxidative damage may also play a role in hemochromatosis-associated retinal pathology.

116 were in participants without a diagnosis of hemochromatosis at baseline.

117 definition of the common form of hereditary hemochromatosis became possible, and testing for the com

118 rss6 could be beneficial in individuals with hemochromatosis, beta-thalassemia, and related disorders

119 from mouse models of iron disorders, such as hemochromatosis, beta-thalassemia, atransferrinemia and

120 thought to be ideal venues for diagnosis of hemochromatosis, but diagnosis rates are often low.

121 viduals with clinically diagnosed hereditary hemochromatosis, but risks are unclear in mostly undiagn

122 ty and mortality in patients with hereditary hemochromatosis, but the precise mechanisms leading to d

123 color, Y chromosome R1b haplotypes, and the hemochromatosis C282Y allele; to our knowledge, the firs

124 It is shown that the characteristics of HFE hemochromatosis can be reproduced by increasing the setp

125 oportin disease (FD) is a form of hereditary hemochromatosis caused by mutations in the iron transpor

126 e numerous, but they are only predisposed to hemochromatosis; complete organ disease develops in a mi

127 Hearts from HFE(-/-) mice with hemochromatosis contained slightly more iron overall tha

128 rs to be the ultimate cause of most forms of hemochromatosis, either due to mutations in the hepcidin

129 ans with a form of hereditary iron overload, hemochromatosis, exhibit loss of beta-cell mass.

130 eviously considered screening for hereditary hemochromatosis for a recommendation as a clinical preve

131 odel of hemochromatosis with deletion of the hemochromatosis gene (Hfe(-/-)).

132 Mitochondrial haplogroups and hemochromatosis gene (HFE) polymorphisms have been assoc

133 wn-regulation of HFE protein [encoded by the hemochromatosis gene (Hfe)] and ferroportin [encoded by

134 allele of Uro-d and two null alleles of the hemochromatosis gene (Uro-d(+/-), Hfe(-/-)) that develop

135 tic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmemb

136 anced greatly with the identification of the hemochromatosis gene and the continued examination of th

137 The C282Y mutation in the HFE hemochromatosis gene occurs more commonly in autoimmune

138 Mice deficient in the hemochromatosis gene, Hfe, have attenuated inflammatory

139 nificant disease in patients who do not have hemochromatosis genotypes.

140 ample, the role of hepcidin dysregulation in hemochromatosis has been a surprising discovery that pro

141 and that hemojuvelin mutants associated with hemochromatosis have impaired BMP signaling ability.

142 Patients with HJV hemochromatosis have low urinary levels of hepcidin, the

143 er studies have suggested that patients with hemochromatosis have poor post-transplantation survival.

144 st a mechanism by which HFE2 mutations cause hemochromatosis: hemojuvelin dysfunction decreases BMP s

145 While mutation in the hemochromatosis ( HFE) gene disrupts iron homeostasis an

146 Retinal expression of GPR91 was higher in hemochromatosis (Hfe(-/-)) mice than in wild-type (WT) m

147 ASO treatment in mice affected by hemochromatosis (Hfe(-/-)) significantly decreased serum

148 ith disruption of two iron regulatory genes, hemochromatosis (Hfe) and transferrin receptor 2 (Tfr2).

149 lly diverse participants that tested for the hemochromatosis (HFE) C282Y genotype and iron status.We

150 The protein product of the hemochromatosis (HFE) gene modulates uptake of iron and

151 Genotyping for hemochromatosis (HFE) gene status was performed.

152 A specific polymorphism in the hemochromatosis (HFE) gene, H63D, is over-represented in

153 c iron overload: mice with a deletion of the hemochromatosis (Hfe) gene, mice fed a high iron diet, a

154 beta2-M interacts with its receptor, hemochromatosis (HFE) protein, to modulate iron responsi

155 including variants at the transferrin (TF), hemochromatosis (HFE), fatty acid desaturase 2 (FADS2)/m

156 verload was studied in two genetic models of hemochromatosis (HFE-null mouse and HJV-null mouse) and

157 ology of such common disorders as hereditary hemochromatosis (HH) and the anaemia of chronic diseases

158 Mutations in HFE lead to hereditary hemochromatosis (HH) because of inappropriately high iro

159 ansferrin receptor 2 (TFR2) cause hereditary hemochromatosis (HH) by impeding production of the liver

160 HFE-associated hemochromatosis (HH) defined as homozygosity for the C28

161 Mutations in the hereditary hemochromatosis (hh) gene (HFE) explain the siderosis in

162 Hereditary hemochromatosis (HH) is a common autosomal-recessive dis

163 Hereditary hemochromatosis (HH) is a common inherited iron overload

164 Hereditary hemochromatosis (HH) is a highly prevalent genetic disor

165 Hereditary hemochromatosis (HH) is an autosomal recessive genetic d

166 Hereditary hemochromatosis (HH) is characterized by increased intes

167 Hereditary hemochromatosis (HH) leads to iron loading because of a

168 ed levels of hepcidin in a murine hereditary hemochromatosis (HH) model increased adipocyte ferroport

169 Type 2 hereditary hemochromatosis (HH) or juvenile hemochromatosis is an e

170 e Hfe and Tfr2 knockout models of hereditary hemochromatosis (HH), signal transduction to hepcidin vi

171 HFE cause the most common form of hereditary hemochromatosis (HH).

172 al complications from HFE-related hereditary hemochromatosis (HH).

173 Here, we provide a comprehensive report of hemochromatosis in a group of patients of Asian origin.

174 By contrast, hemochromatosis in Asia is rare and less well understood

175 genetic screening for HFE-related hereditary hemochromatosis in C282Y homozygotes only.

176 erved in alcoholic liver disease and genetic hemochromatosis in combination with alcohol.

177 P6-SMAD signaling impairment and ameliorates hemochromatosis in Hfe(-/-) mice.

178 h old Hfe-deficient mice, an animal model of hemochromatosis in humans.

179 tment on the molecular defect underlying Hfe hemochromatosis in mice.

180 HFE gene testing can be used to diagnose hemochromatosis in symptomatic patients, but analyses of

181 ion in vivo and in vitro in a mouse model of hemochromatosis in which the gene most often mutated in

182 S who was misdiagnosed and treated as having hemochromatosis, in whom a heterozygous c.-160A>G mutati

183 These causes of hereditary hemochromatosis include defects in genes encoding HFE, t

184 y or susceptibility of developing hereditary hemochromatosis, including the relatives of individuals

185 Wilson disease and genetic hemochromatosis involve defects in metal transport with

186 Both Wilson's disease and genetic hemochromatosis involve defects in the transport of heav

187 ll integrity), FOXC2 (vascular development), hemochromatosis (involved in venous ulceration and iron

188 thogenesis of nearly all forms of hereditary hemochromatosis involves inappropriately low expression

189 Hemochromatosis is a disorder of iron overload arising m

190 Hemochromatosis is a frequent genetic disorder, characte

191 Hereditary hemochromatosis is a genetic disorder of iron metabolism

192 Hereditary hemochromatosis is a heterogeneous group of genetic diso

193 Hereditary hemochromatosis is an autosomal recessive disorder of ir

194 hereditary hemochromatosis (HH) or juvenile hemochromatosis is an early onset, genetically heterogen

195 Hereditary hemochromatosis is an inherited disorder of increased ir

196 Hereditary hemochromatosis is an iron overload disorder that can le

197 Juvenile hemochromatosis is an iron-overload disorder caused by m

198 Hereditary hemochromatosis is an iron-overload disorder resulting f

199 Hemochromatosis is associated not only with excessive ac

200 Type IV hemochromatosis is associated with dominant mutations in

201 Excessive iron is also proangiogenic, and hemochromatosis is associated with iron overload.

202 Hereditary hemochromatosis is caused by mutations in the hereditary

203 HFE-associated hemochromatosis is characterized by abnormally high leve

204 Hereditary hemochromatosis is characterized by tissue iron loading

205 Hereditary hemochromatosis is commonly found in populations of Euro

206 Hemochromatosis is considered by many to be an uncommon

207 anagement of such cofactors in patients with hemochromatosis is important to reduce the risk of liver

208 Because the penetrance of HFE hemochromatosis is low, traditional population screening

209 disease penetrance in HFE-related hereditary hemochromatosis is lower than previously believed, makin

210 Hereditary hemochromatosis is now a complex entity with various cli

211 Hereditary hemochromatosis is predominantly caused by the HFE p.C28

212 Therapeutic phlebotomy for hereditary hemochromatosis is relatively safe and presumably effica

213 The most common form of primary hemochromatosis is that caused by C282Y mutation of the

214 Type 1 hemochromatosis is the most common form of the disease a

215 Diagnosis of hereditary hemochromatosis is usually based on a combination of var

216 Juvenile hemochromatosis (JH) is the most severe form, usually ca

217 ng mutations in the RGMc gene cause juvenile hemochromatosis (JH), a rapidly progressing iron storage

218 uidance molecule c (HJV/RGMc) cause juvenile hemochromatosis (JH), a rapidly progressive iron overloa

219 ule C, RgmC) are the major cause of juvenile hemochromatosis (JH).

220 generated Hepc(-/-) mice (a murine model of hemochromatosis) lacking HIF-2 in the intestine and show

221 Despite reports of skin toxicity in hemochromatosis, little is known about iron levels in sk

222 The mainstay of hemochromatosis management is still removal of iron by p

223 factors have been found to cause late-onset hemochromatosis, many patients have unexplained signs of

224 Thus, individuals with hereditary hemochromatosis may be protected with subunit vaccines b

225 FPN-linked hemochromatosis may have a variable pathogenesis dependi

226 Patients with hemochromatosis may have impairment of iron homeostasis

227 sting that hepatic iron levels in hereditary hemochromatosis may not accurately predict the iron cont

228 However, hereditary hemochromatosis may still cause morbidity and mortality

229 Hemochromatosis mice, cytomegalovirus (CMV) infection of

230 rphism reported for wild-type mice and other hemochromatosis models, hepcidin deficiency and extrahep

231 Finally, unlike most mouse hemochromatosis models, Smad158;Alb-Cre(+) developed liv

232 cidin, are inappropriately low in hereditary hemochromatosis mouse models and patients with HFE mutat

233 In hereditary hemochromatosis, mutations in HFE lead to iron overload

234 st-transplantation survival of patients with hemochromatosis (n = 177) at 1 year (79.1%), 3 years (71

235 In contrast, during 1997-2006, patients with hemochromatosis (n = 217) had excellent 1-year (86.1%),

236 Evidence suggests that most neonatal hemochromatosis (NH) is the phenotypic expression of ges

237 fection outcomes in patients with hereditary hemochromatosis or thalassemia.

238 man immunodeficiency virus, type 2 diabetes, hemochromatosis, or obesity and thus have implications w

239 in healthy controls, with reduced levels in hemochromatosis (P<0.00006) and elevated levels in infla

240 ries not normally associated with hereditary hemochromatosis (Pakistan, Bangladesh, Sri Lanka, and Th

241 o increase physician awareness of hereditary hemochromatosis, particularly the variable penetrance of

242 ted HIV-1 or when infecting macrophages from hemochromatosis patients expressing mutated HFE.

243 Juvenile hemochromatosis patients have decreased urinary levels o

244 icated in the majority of diagnosed juvenile hemochromatosis patients.

245 Loss of Bmp6 in ECs recapitulated the hemochromatosis phenotype of global Bmp6 knockout mice,

246 a iron levels characteristic of the juvenile hemochromatosis phenotype.

247 Defects in human hemochromatosis protein (HFE) cause iron overload due to

248 Mutations in hemochromatosis protein (HFE) or transferrin receptor 2

249 sis is caused by mutations in the hereditary hemochromatosis protein (HFE), transferrin-receptor 2 (T

250 The hereditary hemochromatosis protein HFE promotes the expression of h

251 associated proteins: HJV (hemojuvelin), HFE (hemochromatosis protein), and TfR2 (transferrin receptor

252 Lack of functional hereditary hemochromatosis protein, HFE, causes iron overload predo

253 e morphogenetic protein 6 (BMP6), hereditary hemochromatosis protein, transferrin receptor 2, matript

254 Actions of the hereditary hemochromatosis proteins HFE and transferrin receptor 2

255 ical penetrance of HFE-associated hereditary hemochromatosis, raising the possibility that pharmacolo

256 with primary iron overload due to hereditary hemochromatosis reduce morbidity and mortality compared

257 level and, with the assistance of BMP2/4 and hemochromatosis-related proteins hemojuvelin, HFE and tr

258 hepatic fibrosis and cirrhosis in hereditary hemochromatosis relates to the degree of iron loading, b

259 addressing genetic screening for hereditary hemochromatosis remains insufficient to confidently proj

260 The term hemochromatosis represents a group of inherited disorder

261 2 (TfR2) cause a rare form of the hereditary hemochromatosis, resulting in iron overload predominantl

262 We present a case of neonatal hemochromatosis, review genetic and metabolic causes of

263 This paradox could explain the low yields of hemochromatosis screening reported by some liver clinics

264 understanding of the pathogenesis of primary hemochromatosis, secondary iron overload, and anemia of

265 lved as a modulator of the penetrance of HFE hemochromatosis since fat mass is associated with overex

266 subjects participating in the Scripps/Kaiser hemochromatosis study, only 59 had serum ferritin levels

267 resulting from disorders such as hereditary hemochromatosis, thalassemia, sickle cell disease, and m

268 at increased risk for developing hereditary hemochromatosis that can be readily identified before ge

269 ocyte Smad1/5/8 knockout mice are a model of hemochromatosis that encompasses liver injury and fibros

270 Today, hereditary hemochromatosis, the paradigmatic iron-loading disorder,

271 Compared with recipients without hemochromatosis, those with hemochromatosis were more li

272 In human hemochromatosis, tissue toxicity is a function of tissue

273 We aimed to compare patients with hemochromatosis to those with other causes of liver dise

274 Mutations in hemochromatosis type 2 (HFE2), which encodes the protein

275 HFE2 (hemochromatosis type 2 gene) is highly expressed in skel

276 theless, TFR2 mutations cause iron overload (hemochromatosis type 3) without overt erythroid abnormal

277 ter [ferroportin (Fpn)], are responsible for hemochromatosis type 4, also known as ferroportin diseas

278 ns in this gene result in a form of juvenile hemochromatosis (type 2A).

279 splant survival of patients with and without hemochromatosis using data provided by the United Networ

280 The prevalence of hereditary hemochromatosis was 1 in 169 patients to 1 in 556 patien

281 of iron overload severity in HFE-associated hemochromatosis, we performed exome sequencing of DNA fr

282 e, but genotypes known to be associated with hemochromatosis were absent.

283 heir regulation in the iron-overload disease hemochromatosis were examined.

284 cipients without hemochromatosis, those with hemochromatosis were more likely to die of cardiovascula

285 hological papers on several forms of non-HFE hemochromatosis were published and Wilson's disease was

286 djustment for gene mutations associated with hemochromatosis, were explored.

287 These disorders include various forms of hemochromatosis, which are characterized by inadequate h

288 Hereditary hemochromatosis, which is characterized by inappropriate

289 patients with the common disease hereditary hemochromatosis, which is often caused by an HFE mutatio

290 esis of this increasingly recognized form of hemochromatosis, which responds poorly to conventional t

291 st-transplantation survival of patients with hemochromatosis, which was previously reported to be poo

292 s isolated from a researcher with hereditary hemochromatosis who died from laboratory-acquired plague

293 as of viral and drug hepatitis, fatty liver, hemochromatosis, Wilson disease, several biliary tract d

294 disease, liver cirrhosis, biliary cirrhosis, hemochromatosis, Wilson's disease) and ICC (biliary cirr

295 nery involved in the pathogenesis of genetic hemochromatosis, Wilson's disease, and alpha1-antitrypsi

296 reased insulin secretion in a mouse model of hemochromatosis with deletion of the hemochromatosis gen

297 mutation in ferroportin 1 produced a form of hemochromatosis with excessive iron in hepatocytes and a

298 in C326 Fpn residue produce a severe form of hemochromatosis with iron overload at an early age.

299 Screening for hemochromatosis with serum ferritin levels will detect t

300 mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and ti